Caris Life Sciences (CAI) Enterprise Value: 8.702B

Caris Life Sciences, Inc. (CAI)

32.00 +0.29 (+0.91%) USD | NASDAQ | Oct 23, 16:00

32.00 0.00 (0.00%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2025. Start Trial.

Date	Value
October 23, 2026	8.702B
October 22, 2026	8.620B
October 21, 2026	8.801B
October 20, 2026	8.450B
October 19, 2026	8.337B
October 16, 2026	8.295B
October 15, 2026	8.634B
October 14, 2026	8.209B
October 13, 2026	8.004B
October 12, 2026	8.049B
October 09, 2026	8.052B
October 08, 2026	7.430B
October 07, 2026	7.317B
October 06, 2026	7.418B
October 05, 2026	8.247B
October 02, 2026	7.656B
October 01, 2026	7.671B
September 30, 2026	8.315B
September 29, 2026	8.575B
September 28, 2026	8.631B
September 25, 2026	8.696B
September 24, 2026	8.778B
September 23, 2026	8.603B
September 22, 2026	8.552B
September 21, 2026	8.320B

Date	Value
September 18, 2026	8.131B
September 17, 2026	8.397B
September 16, 2026	7.631B
September 15, 2026	7.713B
September 14, 2026	7.021B
September 11, 2026	6.537B
September 10, 2026	6.453B
September 09, 2026	6.450B
September 08, 2026	6.673B
September 04, 2026	6.744B
September 03, 2026	6.814B
September 02, 2026	6.667B
September 01, 2026	6.662B
August 31, 2026	6.862B
August 28, 2026	6.902B
August 27, 2026	7.114B
August 26, 2026	7.238B
August 25, 2026	7.574B
August 24, 2026	7.043B
August 21, 2026	7.083B
August 20, 2026	6.605B
August 19, 2026	6.091B
August 18, 2026	5.585B
August 17, 2026	5.772B
August 14, 2026	5.820B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks